Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disulfide bond formation is a post-translational modification in proteins, involving the covalent linkage of two cysteine residues through the oxidation of their thiol (-SH) side chains to form a disulfide bridge (-S-S-). This process is critical for stabilizing protein structure, influencing folding, and determining biological function. It occurs primarily in the endoplasmic reticulum of eukaryotes and the periplasm of prokaryotes, often catalyzed by enzymes like protein disulfide isomerases (PDI) and Dsb family enzymes. Disruptions can lead to protein misfolding and related diseases.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disulfide Bond Formation.